What Is Solid-Phase Peptide Synthesis (SPPS)? A Beginner's Guide

Solid-phase peptide synthesis (SPPS) is the dominant method for producing synthetic peptides in research and commercial laboratories. The technique anchors the growing peptide chain to an insoluble polymeric support (resin) while amino acids are added one at a time in a repeating cycle of chemical reactions. Because the peptide remains attached to the solid support throughout synthesis, excess reagents and by-products are removed by simple filtration and washing rather than chromatographic purification after each step. This makes SPPS faster, more efficient, and more amenable to automation than classical solution-phase synthesis.

Modern SPPS can routinely produce peptides up to 40-50 residues in length with high purity. Longer sequences (50-100+ residues) are achievable but require optimized protocols, pseudoproline dipeptides, or chemical ligation strategies. The vast majority of research-grade peptides available from commercial suppliers are manufactured using automated Fmoc-SPPS.

Robert Bruce Merrifield introduced SPPS in 1963, demonstrating that a tetrapeptide (Leu-Ala-Gly-Val) could be assembled on a chloromethylated polystyrene resin. This breakthrough eliminated the need to purify intermediates at each step of peptide chain assembly — a major bottleneck in solution-phase synthesis that limited practical peptide lengths to approximately 10 residues. Merrifield received the 1984 Nobel Prize in Chemistry for this contribution. His original method used Boc (tert-butyloxycarbonyl) chemistry with TFA for temporary deprotection and HF for final cleavage.

The subsequent development of Fmoc (9-fluorenylmethyloxycarbonyl) chemistry by Carpino and Han in 1972 provided a milder, base-labile alternative to Boc chemistry. Fmoc-SPPS avoids the repeated acid exposures of Boc chemistry and the hazardous HF cleavage step, making it safer and more practical for most laboratories. Today, Fmoc-SPPS accounts for over 95% of all solid-phase peptide synthesis performed worldwide.

Fmoc chemistry uses a base-labile temporary protecting group (removed by 20% piperidine in DMF) and acid-labile side-chain protecting groups and resin linker (cleaved by 95% TFA). This orthogonal protection scheme means that temporary and permanent protecting groups are removed under completely different conditions, minimizing premature deprotection. Boc chemistry uses an acid-labile temporary protecting group (removed by 25-50% TFA in DCM) and stronger acid conditions (anhydrous HF or TFMSA) for final cleavage and side-chain deprotection.

Boc chemistry retains advantages for specific applications: it produces cleaner crude peptides for hydrophobic sequences because TFA washes during synthesis help prevent on-resin aggregation. Boc-SPPS is also preferred for synthesizing peptides containing acid-sensitive modifications such as phosphopeptides or glycopeptides where repeated TFA exposure during Fmoc deprotection could cause premature loss of modifications.

Each amino acid addition in SPPS follows a three-step cycle. First, the N-terminal protecting group is removed (deprotection): in Fmoc chemistry, 20% piperidine in DMF cleaves the Fmoc group, releasing dibenzofulvene which is monitored by UV absorption at 301 nm to confirm complete deprotection. Second, the next Fmoc-amino acid is activated and coupled to the free amine of the resin-bound peptide. Coupling typically uses a 3-4 fold excess of activated amino acid for 30-60 minutes. Third, the resin is washed extensively with DMF and DCM to remove excess reagents, by-products, and the base from the deprotection step.

Monitoring coupling efficiency is essential for producing high-purity peptides. The Kaiser (ninhydrin) test detects free primary amines — a positive test (blue beads) after coupling indicates incomplete reaction and the need for recoupling. Chloranil test is used for secondary amines (proline). Automated synthesizers monitor coupling by UV absorbance of the Fmoc-piperidine adduct released during each deprotection cycle.

The resin serves as the insoluble solid support and determines the C-terminal functionality of the final peptide. Wang resin (4-hydroxybenzyl alcohol linker) produces C-terminal carboxylic acids upon TFA cleavage and is the most commonly used resin for Fmoc-SPPS. Rink amide resin (4-(2,4-dimethoxyphenyl-Fmoc-aminomethyl)phenoxy linker) produces C-terminal amides, which are preferred for many bioactive peptides because amidation increases metabolic stability and can enhance receptor binding.

2-Chlorotrityl chloride (2-CTC) resin is used when very mild cleavage conditions are required — peptides can be released with 1% TFA in DCM while retaining all side-chain protecting groups, enabling subsequent fragment condensation in solution. Resin loading capacity (typically 0.2-0.8 mmol/g) affects crude peptide purity: lower loadings reduce inter-chain aggregation on the resin but decrease overall yield per gram of resin.

Coupling reagents activate the carboxyl group of the incoming amino acid to facilitate amide bond formation with the resin-bound peptide amine. HBTU/HOBt and HATU/HOAt are the most widely used uronium/phosphonium-based activators. HATU (1-[bis(dimethylamino)methylene]-1H-1,2,3-triazolo[4,5-b]pyridinium 3-oxide hexafluorophosphate) with DIEA as base provides the fastest coupling kinetics and lowest racemization, making it the reagent of choice for sterically hindered residues and difficult couplings.

DIC (diisopropylcarbodiimide) with Oxyma Pure has emerged as a preferred combination for automated synthesis because it avoids the safety concerns associated with HOBt (which is classified as an explosive) while maintaining excellent coupling efficiency. Preactivation times of 2-5 minutes are recommended to maximize active ester formation before addition to the resin.

Aspartimide formation is the most prevalent side reaction in Fmoc-SPPS, occurring when the beta-carboxyl group of aspartate cyclizes with the backbone nitrogen during piperidine-mediated deprotection. The Asp-Gly, Asp-Ser, and Asp-Asn sequences are particularly susceptible. Using 0.1 M HOBt or Oxyma in the piperidine deprotection solution suppresses aspartimide formation by protonating the aspartate side chain. Backbone amide protection with Hmb (2-hydroxy-4-methoxybenzyl) or Dmb groups provides additional protection for highly susceptible sequences.

Deletion peptides (des-amino acid sequences) result from incomplete coupling and represent the major impurity class in crude SPPS products. Double coupling, extended coupling times, and use of more reactive coupling reagents (HATU over HBTU) reduce deletion peptide content. Racemization during activation is minimized by using pre-formed active esters, avoiding extended preactivation times for histidine and cysteine, and maintaining reaction temperatures below 50C.

The standard Fmoc-SPPS cleavage cocktail is Reagent K: 82.5% TFA, 5% water, 5% phenol, 5% thioanisole, 2.5% ethanedithiol (EDT). TFA cleaves the peptide from the resin and removes all acid-labile side-chain protecting groups simultaneously. The scavengers (water, phenol, thioanisole, EDT) quench reactive carbocations generated during deprotection that would otherwise alkylate sensitive residues (Trp, Tyr, Met, Cys). Cleavage time is typically 2-4 hours at room temperature.

After cleavage, the TFA solution is filtered to remove the spent resin, and the peptide is precipitated by addition of cold diethyl ether or methyl tert-butyl ether (MTBE). The precipitated crude peptide is collected by centrifugation, washed with additional cold ether to remove scavengers and protecting group fragments, and dissolved in water or aqueous acetonitrile for lyophilization. Crude purity of well-optimized syntheses typically ranges from 65-85% for 20-30 residue peptides, with purification by preparative RP-HPLC yielding final purities above 95%.

• Merrifield RB (1963). Solid phase peptide synthesis. I. The synthesis of a tetrapeptide. J Am Chem Soc, 85(14):2149-2154.
• Carpino LA, Han GY (1972). 9-Fluorenylmethoxycarbonyl amino-protecting group. J Org Chem, 37(22):3404-3409.
• Chan WC, White PD (2000). Fmoc Solid Phase Peptide Synthesis: A Practical Approach. Oxford University Press.
• El-Faham A, Albericio F (2011). Peptide coupling reagents, more than a letter soup. Chem Rev, 111(11):6557-6602.
• Subiros-Funosas R et al. (2009). Oxyma: an efficient additive for peptide synthesis. Chemistry, 15(37):9394-9403.
• Lauer JL et al. (2002). Aspartimide formation during SPPS. Int J Pept Res Ther, 9(1):35-43.
• Behrendt R et al. (2016). Advances in Fmoc solid-phase peptide synthesis. J Pept Sci, 22(1):4-27.

• Read more: Understanding HPLC Purity in Peptide Research → https://www.chemverify.com/learn/understanding-hplc-purity-peptide-research
• Read more: What Is an Amino Acid? The Building Blocks of Peptides Explained → https://www.chemverify.com/learn/what-is-amino-acid-building-blocks-peptides
• Read more: Peptide Counterions Explained: TFA, Acetate, HCl, and Their Impact → https://www.chemverify.com/learn/peptide-counterions-tfa-acetate-hcl-impact